The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...

Panelists discuss how the inclusion of ibrutinib on the Inflation Reduction Act (IRA) negotiated drug price list could make it a more economically attractive first-line option, potentially influencing ...

On January 15, 2025, the Internal Revenue Service (the “IRS”) and the Department of the Treasury (“Treasury”) published final regulations ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

CHARLESTON — West Virginia officials are in contact with the administration of President Donald Trump after an executive ...

When the Inflation Reduction Act was signed into law on Aug. 16 ... $5 billion to carry out EIR through Sept. 30, 2026, with a total cap on loans of up to $250 billion. As of Oct. 31, 2024 ...

In 2025, more than 3 million seniors are going to save thousands of dollars because of a new spending limit on prescription drugs. It's unclear whether the Trump Administration will keep the law.

We have received text from H.R. 191: Inflation Reduction Act of 2025 ... issues of inflation, energy costs, healthcare, and other areas covered by the 2022 Act.

The cap is part of the Inflation Reduction Act ... bill when total spending met a certain threshold. Five cancer drugs − Revlimid, Pomalyst, Imbruvica, Jakafi, and Ibrance − cost Medicare ...

CHARLESTON — West Virginia officials are in contact with the administration of President Donald Trump after an executive ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.